Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 4
2009 3
2016 2
2017 1
2018 3
2019 4
2020 2
2021 6
2022 2
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.
Aoki M, Miyata R, Kamimura G, Harada Takeda A, Suetsugu T, Mizuno K, Ueda K. Aoki M, et al. Among authors: suetsugu t. Ann Thorac Cardiovasc Surg. 2024 Jan 26;30(1):23-00134. doi: 10.5761/atcs.oa.23-00134. Epub 2023 Dec 16. Ann Thorac Cardiovasc Surg. 2024. PMID: 38105006 Free PMC article.
Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review.
Matsuyama T, Oniwa M, Tsuruzono K, Yasuda S, Yone M, Tomioka Y, Uchida A, Mitsuyama H, Kubota S, Suetsugu T, Mizuno K, Inoue H. Matsuyama T, et al. Among authors: suetsugu t. Respirol Case Rep. 2023 Nov 30;12(1):e01262. doi: 10.1002/rcr2.1262. eCollection 2024 Jan. Respirol Case Rep. 2023. PMID: 38045825 Free PMC article.
Successful Treatment with Osimertinib Based on Therapeutic Drug Monitoring in a Hemodialysis Patient with Non-Small Cell Lung Cancer: A Case Report.
Tabata K, Aoki M, Miyata R, Umehara T, Harada-Takeda A, Kamimura G, Nagata T, Okizono R, Terazono H, Takeda Y, Suetsugu T, Ueda K, Sato M. Tabata K, et al. Among authors: suetsugu t. Case Rep Oncol. 2023 Aug 22;16(1):705-710. doi: 10.1159/000531840. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37936662 Free PMC article.
Detecting acquired V-Raf murine sarcoma viral oncogene homolog B1 V600E mutation associated with osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma: A case report.
Hagihara Y, Suetsugu T, Uto H, Kozono T, Masada Y, Satozono Y, Shinmura M, Koreeda Y, Mizuno K, Inoue H. Hagihara Y, et al. Among authors: suetsugu t. Respir Investig. 2024 Jan;62(1):13-15. doi: 10.1016/j.resinv.2023.09.006. Epub 2023 Nov 3. Respir Investig. 2024. PMID: 37925883
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers.
Kurose K, Sakaeda K, Fukuda M, Sakai Y, Yamaguchi H, Takemoto S, Shimizu K, Masuda T, Nakatomi K, Kawase S, Tanaka R, Suetsugu T, Mizuno K, Hasegawa T, Atarashi Y, Irino Y, Sato T, Inoue H, Hattori N, Kanda E, Nakata M, Mukae H, Oga T, Oka M. Kurose K, et al. Among authors: suetsugu t. Adv Clin Chem. 2023;112:155-204. doi: 10.1016/bs.acc.2022.09.004. Epub 2022 Nov 17. Adv Clin Chem. 2023. PMID: 36642483 Review.
33 results